Lifestyle Factors Complementary strategies to support hormonal health alongside the protocol
FDA approved a new indication for semaglutide (Wegovy) to reduce the risk of cardiovascular death, myocardial infarction, and stroke in adults with CVD and either obesity or overweight ( 3.2 Neurological and psychosocial protection GLP-1RAs have demonstrated growing potential in neurological and psychosocial disorders
It gives me that kick in the morning
Lixisenatide reduces chylomicron triacylglycerol by increased clearance
Clients with underlying medical issues and/or a history of poor health, diabetes, thyroid conditions, endocrine conditions, or any other health-related conditions that may contribute to weight gain or a compromised metabolism may not respond to the proposed treatment and/or may require additional treatment sessions.
Meanwhile, for many years now, scientists have studied the effects of low-dose naltrexone (LDN) on the gut epithelial barrier in treatment-resistant Ulcerative colitis patients